Zura Bio Limited (ZURA) annual income statement — 5-year revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - |
| Cost of Goods Sold | 16K | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - |
| Gross Profit | -16K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - |
| Operating Expenses | 81.49M | 75.25M | 55.19M | 62.64M | 27.16M | 1.09M |
| OpEx % of Revenue | - | - | - | - | - | - |
| Selling, General & Admin | 35.14M | 33.16M | 30.79M | 18.64M | 3.47M | 1.09M |
| SG&A % of Revenue | - | - | - | - | - | - |
| Research & Development | 46.35M | 42.08M | 24.4M | 44M | 23.69M | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -81.49M | -75.25M | -55.19M | -62.64M | -27.16M | -1.09M |
| Operating Margin % | - | - | - | - | - | - |
| Operating Income Growth % | - | -36.34% | 11.89% | -130.61% | -2387.39% | - |
| EBITDA | -81.44M | -75.2M | -55.18M | -62.64M | -27.16M | 8.42M |
| EBITDA Margin % | - | - | - | - | - | - |
| EBITDA Growth % | -23.3% | -36.28% | 11.91% | -130.61% | -422.72% | - |
| D&A (Non-Cash Add-back) | 56K | 49K | 9K | 0 | 0 | 0 |
| EBIT | -81.49M | -75.25M | -55.19M | -62.64M | -27.16M | 8.42M |
| Net Interest Income | 5.84M | 6.34M | 8M | 2.19M | 570 | 23.48K |
| Interest Income | 5.84M | 6.34M | 8M | 2.19M | 570 | 23.48K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 6.06M | 6.6M | 2.79M | 2.08M | -171K | 9.51M |
| Pretax Income | -75.43M | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
| Pretax Margin % | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -75.43M | -68.65M | -52.4M | -60.36M | -25.74M | 8.42M |
| Net Margin % | - | - | - | - | - | - |
| Net Income Growth % | -31.14% | -31% | 13.18% | -134.52% | -405.8% | - |
| Net Income (Continuing) | -75.43M | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 13.2M | 20.22M | 10M | 0 |
| EPS (Diluted) | -0.67 | -1.06 | -0.60 | -2.09 | 0.21 | 0.40 |
| EPS Growth % | -29.76% | -76.67% | 71.29% | -1095.24% | -47.5% | - |
| EPS (Basic) | - | -1.06 | -0.60 | -2.09 | 0.21 | 0.40 |
| Diluted Shares Outstanding | 112.22M | 94.16M | 75.07M | 33.06M | 17.25M | 17.25M |
| Basic Shares Outstanding | 112.22M | 94.16M | 75.07M | 33.06M | 17.25M | 17.25M |
| Dividend Payout Ratio | - | - | - | - | - | - |
Quick answers to the most common questions about buying ZURA stock.
For fiscal year 2025, Zura Bio Limited (ZURA) reported total revenue of $0.0M.
Zura Bio Limited (ZURA) reported a net loss of $68.7M for the fiscal year ending 2025.